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domain, suggesting a new regulatory
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Regulation of c-Src activity by the intrinsically disor-
dered Unique domain has recently been demon-
strated. However, its connection with the classical
regulatory mechanisms is still missing. Here we
show that the Unique domain is part of a long loop
closed by the interaction of the SH4 and SH3 do-
mains. The conformational freedom of the Unique
domain is further restricted through direct contacts
with SH3 that are allosterically modulated by binding
of a poly-proline ligand in the presence and in the
absence of lipids. Our results highlight the scaf-
folding role of the SH3 domain for the c-Src N-termi-
nal intrinsically disordered regions and suggest a
connection between the regulatory mechanisms
involving the SH3 and Unique domains.
INTRODUCTION
The non-receptor protein kinase c-Src was the first proto-onco-
gene to be discovered and it plays a critical role in mediating
signal transduction in multiple pathways (Martin, 2001) related
to cell migration, invasion, and survival, all of which contribute
to its oncogenic potential. High levels of c-Src activity have
been associated with a poor prognosis in colorectal, prostate,
and breast cancers (Sirvent et al., 2012; Yeatman, 2004; Hynes,
2000). However, c-Src mutations are seldom found in cancer
cells, suggesting that the transforming potential is associated
with failures in c-Src regulation.
The c-Src domain structure, which is shared with the other
members of the Src family of kinases (SFKs), consists of four
Src-homology domains: SH4, SH3, SH2, and SH1, arranged
in this order from the N terminus to the C terminus, with the
Unique domain separating the SH4 and SH3 domains (Fig-
ure 1A). The SH1 domain is the enzymatically active kinase
domain. The SH4 domain contains lipid substitutions and is pri-
marily responsible for anchoring the SFKs to membranes. In the
case of c-Src, it contains a myristoyl group attached to the N
terminus. Positively charged residues in the SH4 domain alsoStructure 23contribute to the interaction with negatively charged mem-
branes (Resh, 1999). The Unique domain is intrinsically disor-
dered and has the capacity to interact with lipids, other proteins
such as calmodulin, and the adjacent SH3 domain (Pe´rez et al.,
2013a).
The SH3 and SH2 domains are regulatory domains. The inter-
action of the SH2 domain with a phosphorylated tyrosine located
near the C terminus contributes to maintain c-Src in a closed
basal state that is enzymatically inactive. The viral forms of Src
(v-Src) missing the C-terminal tyrosine are constitutively active
(Martin, 2001) but various v-Src forms display different levels of
activity indicating additional levels of regulation (Reddy et al.,
1990; Bra´bek et al., 2002). Structurally, the Y530F mutant of hu-
man c-Src remains 85% in its closed form (Bernado´ et al., 2008).
This second layer of regulation has been associated with interac-
tions involving the SH3 domain, including binding to a proline-
rich region in the linker connecting the SH2 and SH1 domains
(Xu et al., 1999), as well as interactions not related to poly-proline
binding and involving the nSrc andRT loops (Bra´bek et al., 2002).
SH3 domains are one of the most abundant domain families in
eukaryotes, with about 300 occurrences in the human genome
(Ka¨rkka¨inen et al., 2006). SH3 domains are small (60–70 resi-
dues) and consist of a b-sandwich formed by five or six b-strands
connected by three loops (the RT, nSrc, and distal loops) and a
short 310 helix (Figures 1B and 1C).
In addition to the canonical interaction with PxxP sequences
(Cheadle et al., 1994; Rickles et al., 1994; Feng et al., 1995),
the SH3 domain of c-Src interacts with lipids and the Unique
domain (Pe´rez et al., 2013a). The SH3 residues directly interact-
ing with PxxP segments and the Unique domain are located in
opposite sides of the domain. However, binding of a high-affinity
poly-proline peptide to the SH3 domain allosterically modulates
the interaction with the Unique domain (Pe´rez et al., 2013a).
The functional role of the Unique domain has remained
obscure until very recently.
Residues 60–67 in the Unique domain form the Unique lipid-
binding region (ULBR) (Figure 1B) with residual structure even
in the isolated domain (Pe´rez et al., 2009). Lipid binding was
abolished by replacing residues 63–65 (LFG) by three alanines
(Pe´rez et al., 2013a). This mutation, which we refer to as AAA,
causes strong phenotypes when introduced in full-length c-Src
and expressed in Xenopus laevis oocytes (Pe´rez et al., 2013a)
or in human colorectal cancer cells (unpublished)., 893–902, May 5, 2015 ª2015 Elsevier Ltd All rights reserved 893
Figure 1. Domain Structure and Amino Acid
Sequence of USrc-SH3 of Human c-Src
(A) Domain structure of c-Src and regulatory in-
teractions. Classical interactions of the SH2
domain with phosphotyrosine, the SH3 domain
with a proline-rich connector linking SH2 and SH1,
and SH4 with lipids are indicated in black. New
interactions reported here are shown in red.
(B) Residues 1–85 (SH4 and Unique domains) are
shown in black. Residues 86–150 (SH3 domain)
are shown in gray. The secondary structure ac-
cording to Wang et al. (2001) is represented on top
of the sequence. c-Src SH3 residues that are in
direct contact with the core sequences of poly-
proline ligand (Feng et al., 1995) are highlighted in
brown. SH4 domain, red; Unique lipid-binding re-
gion (ULBR), light blue; RT loop, green; nSrc loop,
dark blue; distal loop, gold. The SH4 domain is
divided into two subdomains (see text for details).
(C) Crystal structure of the SH3 domain of human
c-Src (PDB ID code 4HXJ). The color code is the
same as in (B).These results strongly suggest that the Unique domain forms a
new layer of regulation for c-Src but raise the question of how
this new regulation mechanism is connected with the classical
ones involving the SH3 and SH2 domains. Figure 1A summarizes
the previously and newly described regulatory interactions and
highlights the central role of the SH3 domain. In this work, we
show the SH3 domain acting as a scaffold for the intrinsically
disordered Unique domain, the interaction between the SH3
and the SH4 domains closing a long loop including the entire
Unique domain, the direct interaction of the SH3 domain with
lipids, and the allosteric modulation of SH3 binding to the Unique
domain and lipids by its canonical interaction with a poly-proline
peptide.
RESULTS
Interaction of SH3 with the Unique and SH4 Domains
of c-Src
Nuclear magnetic resonance (NMR) chemical shift perturbations
(CSPs) were used tomap the residues affected by the interaction
between SH3 and the disordered regions of c-Src (USrc = SH4 +
Unique domains). They were determined by comparing 1H-15N
heteronuclear single quantum correlation (HSQC) NMR spectra
of a linked multi-domain construct (USrc-SH3, residues 1–150)
with those of shorter peptides containing the individual compo-
nents (USrc, residues 1–85; SH3, residues 86–150). The pep-
tides and proteins used are summarized in Table 1. Figure 2
shows the sequence-specific combined 15N and 1H CSP
measured at pH 7.0. Figure 2A shows the results for the disor-
dered regions measured at 278 K to minimize proton amide ex-
change. Disregarding amino acids close to the linkage region
(83–89), T37, A55, E60, K62, and N68 in the Unique domain
and K5, S6 in the SH4 domain are the most affected residues.
Residues 2–4 are not observable due to fast exchange at this
pH and temperature. Figure 2B shows the SH3 residues whose
chemical shifts are affected by the presence of the Unique and
SH4 domains at 298 K. The main changes in the SH3 domain
are observed in the nSrc loop, around V114, and the RT loop894 Structure 23, 893–902, May 5, 2015 ª2015 Elsevier Ltd All rights(R98, D102). Perturbations are also observed in residues around
H125 and T132 flanking the distal loop, and in residues located in
the 310 helix and the C-terminal region.
SH3 domains recognize poly-proline sequences. The binding
site is formed mainly by aromatic residues on the SH3 surface
(highlighted in Figures 1B and 1C) but ligand binding effects
propagate across the SH3 domain through a hydrogen bond
network (Wang et al., 2001; Cordier et al., 2000) extending to
the RT loop and residues located on the opposite side of the
poly-proline ligand binding site. We had previously reported
the allosteric modulation of Unique domain binding by the addi-
tion of a poly-proline peptide (PPP) with the sequence Ac-
VSLARRPLPPLP-OH, which is a consensus high-affinity SH3
ligand (Pe´rez et al., 2013a; Feng et al., 1995). Interestingly, the
interaction between the SH3 domain and residues in the SH4
domain is not affected by the presence of the PPP ligand. This
is clearly seen in Figure 2C in which similar large differences in
chemical shifts for residues K5 and S6 are observed between
USrc and USrc-SH3 in the presence and in the absence of
PPP. In contrast, many of the Unique domain residues that
were most affected by the interaction with the SH3 domain
(T37, A55, E60, K62) have very similar chemical shift values
in USrc and USrc-SH3 in the presence of the PPP ligand, indi-
cating that those amino acids sense an environment similar to
that of USrc.
Differences in chemical shifts of SH3 residues in the SH3-PPP
complex and in the USrc-SH3-PPP complex map the regions of
the SH3 domain that are interacting with USrc in the presence of
the PPP ligand. Figure 2D clearly shows that the interactions
involving the nSrc loop are retained, while most of the other inter-
acting regions disappear in the SH3-PPP complex. Since only
the N-terminal region of the SH4 domain retains its interaction
in the presence of PPP, it can be concluded that this region of
the SH4 domain interacts with the nSrc loop of SH3 in the
SH3-PPP complex. The similar chemical shifts of residues K5
and S6 in the apo and PPP-bound forms of USrc-SH3 suggest
that these residues are also interacting with the nSrc loop in
the apo protein, and that the RT loop interacts with the Uniquereserved
Table 1. Truncated Forms of c-Src Used in this Study
Acronym Residues Description Modifications
USrc-SH3 WT 1–150 SH4-Unique-SH3 GAa at N terminus
USrc-SH3-AAA 1–150 SH4-Unique-SH3 GA at N terminus
63LFG65-63AAA65
USrc-SH3-WT-
MTSL
1–150 SH4-Unique-SH3 GA at N terminus
A59C-MTSL
USrc-SH3-AAA-
MTSL
1–150 SH4-Unique-SH3 GA at N terminus
63LFG65-63AAA65
A59C-MTSL
USrc WT 1–85 SH4-Unique STb at C terminus
USrc-AAA 1–85 SH4-Unique ST at C terminus
63LFG65-63AAA65
USrc-WT-MTSL 1–85 SH4-Unique ST at C terminus
A59C-MTSL
USrc-AAA-MTSL 1–85 SH4-Unique ST at C terminus
63LFG65-63AAA65
A59C-MTSL
SH3 86–150 SH3 GA at N terminus
SH4 peptide 2–19 SH4 –
aResidues located before Methionine 1 after TEV cleavage.
bST, Strep-tag (SAWSHPQFEK).domain in the absence of the PPP ligand but this interaction is
lost in the PPP complex. The regions of the SH3 domain interact-
ing with the disordered domains in the absence and in the pres-
ence of PPP are indicated in Figures 2E and 2F.
The USrc region is covalently connected to the SH3 domain
but also anchored to the SH3 domain by the N-terminal part of
the SH4 domain closing a 78-residue-long loop including the re-
maining residues of the SH4 domain and the complete Unique
domain. Additional contacts between residues in the Unique
domain and SH3 further decrease its conformational freedom.
The contacts with the Unique domain are lost in the PPP com-
plex but a flexible loop is retained. The chemical shifts of NH
groups of residues in the hinge region connecting the SH3 and
Unique domains (residues S75–G85) are clearly affected by
PPP binding to SH3, probably reflecting local changes caused
by the loss of interactions along the Unique domain affecting
the overall loop geometry.
TheUniqueDomainDirects the Interaction Site of SH4 in
the SH3 Domain
The interaction between the SH4 and SH3 domains was
confirmed using a synthetic peptide with the sequence of the
SH4 domain (SH4 peptide, residues 2–19, GSNKSKPKDA
SQRRRSLE).
Figure 3A shows the CSPs induced by the addition of a 10-fold
excess of SH4 peptide to 100 mM SH3. In this experiment, the
most perturbed residues are located in the RT loop, with the
charged residues R98 and E100 most affected. Additional
effects are observed in residues located or flanking the distal
loop (H125, G130, T132), with minor effects observed in the
nSrc loop. The nSrc loop is the most perturbed region of the
SH3 domain when the SH4 and SH3 domains are connected
by the Unique domain, both in the presence and in the absence
of PPP peptide. The addition of SH4 peptide to the complexStructure 23formed between SH3 and PPP induces chemical shift changes
in the RT loop that are much smaller than in the case of apo-
SH3 (Figure 3C). However, the effects in the nSrc and distal
loop are similar and very small, in contrast to the large chemical
shift changes in the nSrc loop observed when the PPP com-
plexes of SH3 and USrc-SH3 are compared (Figure 2D). Thus,
the Unique domain facilitates the interaction between the SH4
and nSrc loop both in the apo forms, where the Unique domain
directly interacts with the SH3 domain, and in the PPP complex,
where the direct Unique-SH3 interaction is lost.
The capacity of a 78-residue flexible peptide chain to deter-
mine the interaction site of the SH4 domain is a surprising result
considering the intrinsically disordered nature of the Unique
domain. Previous NMR studies of the USrc protein had
confirmed its intrinsically disordered nature but had identified a
short segment between residues 60 and 75 with residual struc-
ture (Pe´rez et al., 2009).We decided to use a previously designed
mutant (Pe´rez et al., 2013a) in which residues 63–65 (LFG) had
been replaced by alanines (AAA) to investigate the effects of
Unique domain residual structure.
The AAA Unique Domain Mutant Retains the
Interactions with the SH3 Domain
Figure 4 shows plots of sequence-dependent chemical shift dif-
ferences obtained by comparing USrc-SH3-AAA, USrc-AAA,
and SH3 following the same approach used for the wild-type
(WT) construct (cf. Figure 2).
The perturbations induced by the WT and AAA forms of USrc
in the NH chemical shifts of SH3 residues are similar. In partic-
ular, residues around V114 in the nSrc loop are the most per-
turbed also in the AAA mutant (cf. Figures 2B and 4B). The RT
loop is also affected, although R98 and D102 show smaller
chemical shift changes than in the WT construct. Small reduc-
tions in the chemical shift changes are also observed in the other
loops although, overall, the same regions are affected.
USrc residues outside the mutation site show a very similar
perturbation profile in the WT and AAA forms (cf. Figures 2A
and 4A), confirming that the AAA mutation preserves most of
the interaction sites between the Unique and SH3 domains,
although the overall interaction is weaker.
Chemical shift differences may originate from direct contacts
or indirect effects. To confirm the interaction between the Unique
and SH3 domains, we used paramagnetic relaxation enhance-
ment (PRE) by a paramagnetic center (methane thiosulfonate
derivative spin-label [MTSL]) attached to a cysteine residue
introduced at position 59 (close to the ULBR) of the WT and
AAA mutants of USrc-SH3 constructs.
Proximity of the unpaired electron center induces fast relaxa-
tion of the NMR signals, which translates into line broadening
and decreased intensity. A reference spectrum is obtained by
reducing the spin label with an excess of ascorbic acid. Results
are presented as the intensity ratio between the oxidized and
reduced samples.
Figure 5 compares the PRE effects of a spin label located at
position 59 of the Unique domain in WT and AAA USrc-SH3.
The most affected regions in the SH3 domain (highlighted) are
similar. Residues in the distal loop and the RT loop are less
affected by the spin label in the AAA mutant than in the WT, in
agreement with the chemical shift perturbation results., 893–902, May 5, 2015 ª2015 Elsevier Ltd All rights reserved 895
Figure 2. SH3 Inter-domain Interactions
(A–D) Combined absolute value 1H-15N NMR chemical shift changes between linked and isolated domains. (A and C) USrc-SH3 versus USrc at 278 K. (B and D)
USrc-SH3 versus SH3 at 298 K. (C) and (D) were measured in the presence of 1 equivalent of PPP while no SH3 ligand was added in (A) and (B). Asterisks (*) mark
residues whose chemical shift differences are off-boundaries of the plots: K5* Dd value is 0.18 ppm (A and C) and V86* Dd value is 0.14 ppm (B) and 0.13 ppm (D).
V114* Dd value is 0.12 ppm. All spectra were measured at pH 7.0 and at a protein concentration of 0.2 mM. Combined NH chemical shift differences (Dd) were
computed as in Equation 1 (see Experimental Procedures). Gray circles indicate proline residues. The dashed line represents one SD.
(E and F) SH3 residues perturbed by the presence of USrc in the absence (E) and in the presence of PPP (F) are highlighted on the SH3 structure (PDB entry 4HXJ).Long-Range Intra-domain Contacts in the Unique
Domain Are Perturbed in the AAA Mutant
PRE effects on NH signals of peaks within the Unique domain
show a complex pattern indicative of long-range contacts
that is different for the WT and AAA proteins. In order to
focus on the interactions within the USrc region, indepen-
dently of additional interactions with the SH3 domain, we
measured PREs in the isolated WT and AAA forms of USrc
(Figures 6A and 6B). The PRE pattern as a function of the
position along the sequence in the WT protein is not compatible
with that expected for a random coil, indicated by the contin-896 Structure 23, 893–902, May 5, 2015 ª2015 Elsevier Ltd All rightsuous gray line. Deviations from the predictions of the ideal
random-coil model are lower in the AAA mutant than in WT
USrc, suggesting that residues replaced by the AAA mutation
have a direct influence in the restricted conformational space
(compared with a random coil) sampled by the isolated Unique
domain.
Lipid Binding by USrc-SH3: De-convoluting Lipid and
Inter-domain Interactions Using PPP Binding
The SH3 domain binds to lipids through the RT and nSrc loops.
The affected residues are the same in the isolated SH3 domainreserved
Figure 3. SH3-SH4 Domains Interaction
(A) Combined absolute value 1H-15N NMR chemical shift changes between the
SH3 domain alone and in the presence of a 10-fold excess of SH4 peptide.
(B) SH3 residues perturbed by the presence of a 10-fold excess of SH4 peptide
are highlighted on the SH3 structure (PDB entry 4HXJ).
(C) 1H-15N NMR CSPs between SH3-PPP complex and SH3-PPP in the
presence of a 10-fold excess of SH4 peptide. Combined NH chemical shift
differences (Dd) were computed as in Equation 1 (see Experimental Pro-
cedures). Gray circles indicate proline residues. The dashed line represents
one SD.(Pe´rez et al., 2013a), USrc-SH3 WT, and USrc-SH3 AAA
(Figure S1).
Since PPP binding to SH3 affects the RT loop, we tested its
effect on lipid binding. Figures 7A and 7B show the result of
adding dihexanoyl phosphatidylcholine (DHPC)-dimyristoyl
phosphatidyl glycerol (DMPG) bicelles in the NH chemical shiftsStructure 23of the apo- and PPP-bound forms of USrc-SH3. PPP binding
nearly completely abolished direct lipid interaction of the SH3
domain but preserved those of residues 64–67 (ULBR) and 14–
17 in the C-terminal part of the SH4 domain.
However, while the chemical shifts of NH groups from ULBR
residues of USrc-SH3 in the presence of PPP but without lipids
are the same as in USrc, the corresponding chemical shifts of
the USrc-SH3-PPP complex in the presence of lipids do not
coincide with those of USrc bound to lipids. These observations
suggest that, although direct interaction of the ULBR with the
SH3 domain is lost in the PPP complex, lipid binding by the
ULBR is affected by the proximity of the SH3 domain.
This observation is consistent with retention of the interaction
of the SH4-SH3 interaction in the PPP complex.
Residues T37 and K62 interact with apo-SH3 but not with
lipids. In the PPP complex, these residues show the same
chemical shift as in USrc, confirming that PPP abolishes the
direct interaction of the Unique and SH3 domains also in the
presence of lipids. The chemical shifts of residues A55 and
E60 in the absence of PPP are affected by the addition of
lipids (Figures 7B and S2) and by the interaction with the SH3
domain (Figure 2A). In the PPP complex, both interactions are
abolished. Thus, PPP binding prevents the lipid interaction of
residues 55 and 60 but not that of the ULBR. Residues 72
and 78 are perturbed by the addition of lipids only in the PPP
complex. Considering that these residues are close to the
Unique domain-SH3 hinge region, it is unclear whether the
observed chemical shift changes represent direct lipid interac-
tions or variations in the conformation of the hinge region
induced by the interaction of the SH4 and ULBR with the lipid
surface.
Figures 7C and 7D show the effect of adding PPP to USrc-SH3
in the presence of bicelles. Residues in the hinge region (72–85)
are also strongly perturbed by PPP binding (Figure 7C). Those
residues experience CSPs of the same order as those observed
by USrc-SH3-PPP binding in the absence of lipids (Figure 2C)
suggesting that the 78-residue loop formed by the interaction
between the SH4 and SH3 domains is preserved in the presence
of lipids and its conformational space is affected when the addi-
tional contacts with the Unique domain are eliminated in the PPP
complex.
Chemical shifts of the SH4 and SH3 residues that are mutually
interacting in the absence of lipids are a good monitor for the
persistence of this interaction. For example, the absence of
chemical shift changes upon addition of PPP indicates that the
SH3-SH4 interaction is conserved. The addition of PPP has
the further effect of eliminating direct interactions between the
SH3 and lipids. Therefore, the absence of chemical shifts in
the SH3 region of the USrc-SH3-PPP complex in the presence
of lipids (Figure 7B) is an additional indication of the conservation
of the Unique domain loop. Similarly, the chemical shifts of res-
idues 6 and 7 of the SH4 domain in the presence of lipids and
PPP are very similar to those observed in the absence of lipids
confirming that the SH4-SH3 interaction is preserved in the pres-
ence of lipids.
The SH4 domain is known to be the primary anchoring site of
c-Src to membranes but we have shown that it also interacts
with the SH3 domain. This raises the question of how SH4 bind-
ing to lipids and the SH3 domain affect each other., 893–902, May 5, 2015 ª2015 Elsevier Ltd All rights reserved 897
Figure 4. ULBR Mutations Partially Affect Inter-domain Interactions
Combined absolute value 1H-15N NMR chemical shift changes between linked and isolated domains measured at pH 7.0. Asterisks (*) mark residues whose
chemical shift differences are off-boundaries of the plots.
(A) USrc-SH3-AAA versus USrc-AAA at 278 K. K5* Dd value is 0.11 ppm.
(B) USrc-SH3-AAA versus SH3 at 298 K. V86* Dd value is 0.14 ppm.
Proline residues are shown as gray circles. Dashed lines correspond to one SD.The SH4 domain includes the first 19 residues of c-Src.
However, from our data, it appears to be composed of two
regions (nSH4 and cSH4). Residues 5–7 (and possibly the
preceding, not observed residues) form the N-SH4 subdo-
main that binds the SH3 domain and are only marginally
affected by lipids (at least in the non-myristoylated con-
structs). Residues 12–19 constitute the cSH4 subdomain
that shows the largest perturbations in the presence of nega-
tively charged lipids (Figure 7A). In the USrc-SH3-PPP com-Figure 5. PRE Experiments in Spin-Labeled USrc-SH3 Constructs
Intensity ratios of NH cross peaks from MTSL-labeled A59C-USrc-SH3 WT (A)
diamagnetic (reduced) forms. The most affected regions in the SH3 domain are
898 Structure 23, 893–902, May 5, 2015 ª2015 Elsevier Ltd All rightsplex, the interaction of cSH4 residues with lipids is main-
tained (and extended to include A21 in the Unique domain,
Figure 7B). The chemical shifts of nSH4 residues are less
affected by lipids and show similar changes in the apo and
PPP-bound forms. The observed lipid-induced shifts in
nSH4 may indicate that either this region is simultaneously in-
teracting with lipids and the SH3 domain or that they are
affected by changes in the lipid-binding mode of the neigh-
boring cSH4 subdomain. In any case, the SH4 domain as aand A59C-USrc-SH3-AAA mutant (B) between paramagnetic (oxidized) and
highlighted. M, MTSL; gray circles indicate proline residues.
reserved
Figure 6. Effect of AAA Mutation on Long-Range Interactions within
the Unique Domain
Intensity ratios of NH cross peaks from MTSL-labeled A59C-USrc WT (A),
A59C-USrc-AAA mutant (B) between paramagnetic (oxidized) and diamag-
netic (reduced) forms. The gray line corresponds to the theoretical PREs
computed from the random-coil definition (see Experimental Procedures).
M, MTSL; gray circles indicate prolines.whole simultaneously interacts with lipids and the SH3
domain.
Interestingly, the boundary between nSH4 and cSH4 in-
cludes D10, the only negatively charged residue in the
strongly positively charged domain. This residue and its first
neighbor A11 are not observable in the NMR spectra of
USrc-SH3-PPP complex in the presence of bicelles, probably
due to exchange broadening as is often observed in hinge
regions.
DISCUSSION
c-Src regulation through inter-domain interactions involving the
folded SH2, SH3, and kinase domain, as well as the regulatory
C-terminal tail has been extensively studied. The SH4 domain
is mainly associated with the capacity of c-Src to interact with
lipids, while the role of the intrinsically disordered Unique domain
remains poorly understood despite recent findings (Pe´rez et al.,
2013a).
Here, we have shown that the RT, nSrc, and distal loops in the
SH3 domain play a key role in the conformational properties of
the flexible SH4 and Unique domains. We have also shown
that binding of a poly-proline ligand to the SH3 domain allosteri-
cally affects the interactions involving the RT and nSrc SH3
loops, and therefore, directly influences the conformational
space sampled by the Unique domain. Figure 8 shows a cartoon
representation summarizing the contacts between the SH4,
Unique, and SH3 domains in the absence and presence of lipidsStructure 23aswell as the effect of PPP binding to the SH3 domain or the AAA
mutation in the Unique domain.
The regulatory role of the Unique domain has been demon-
strated by the phenotypic effects caused by the introduction
of the AAA mutation in the full-length protein expressed in
a constitutively active form in Xenopus laevis oocytes and
in colorectal SW620 cancer cells (unpublished). Regulatory
inputs may include the known interactions of the Unique domain
with lipids, with calmodulin (Pe´rez et al., 2013a), or
its phosphorylation at various serine and threonine sites
(Pe´rez et al., 2009; Amata et al., 2013). How these inputs
are converted to changes in kinase activity or selectivity
remains to be understood. The SH3 domain seems to be
playing the role of an interaction hub connecting the flexible
SH4 and Unique regions with the folded domain (SH1, SH2,
SH3) cluster.
Independent evidence supporting the connection between
the SH3 and Unique domains can be found by comparing
the sequences of various v-Src forms (Table S1) in which, in
addition to the missing regulatory tail, simultaneous mutations
in the ULBR and the RT loop of the SH3 domain are observed.
These data are in agreement with the present NMR study indi-
cating that the Unique domain preferentially interacts with the
RT loop.
The flexible SH4 and Unique domains of c-Src sample a
restricted conformational space determined by long-range
interactions including the SH3 domain. Ligand binding to
the SH3 domain allosterically modulates some of these interac-
tions but intra-domain contacts within the Unique domain
are also important. The AAAmutation, which was experimentally
observed to cause strong phenotypes when introduced in full-
length c-Src, reduces some of these interactions leading to a
more random-coil type conformation in the Unique
domain. The same mutation destroys the Unique domain lipid-
binding region (Pe´rez et al., 2013a) but does not substantially
modify the interactions of the Unique and SH4 domains with
SH3 even in the presence of a PPP (Figure S3). Therefore,
perturbation of the lipid binding remains the most probable
mechanism for the phenotypic effects of the AAA full-length
mutant, although more subtle effects related to its perturbation
of the Unique domain conformational space cannot be ruled out.
Binding of a poly-proline ligand to the SH3 domain induces
an allosteric regulation of the interactions involving the RT
loop. Two of these interactions have been observed: binding
of lipids by the SH3 domain and the interaction with the
Unique domain. Interestingly, the interaction between the
SH4 and SH3 domains in the USrc-SH3 construct is not
affected by ligand binding and, therefore, the Unique domain
is not completely released, although the direct contacts with
the SH3 domain are lost. This mechanism is conserved even
when the molecule is interacting with lipid membranes. Thus,
the SH3 domain remains close to the Unique domain and to
the lipid surface even though the direct interactions with lipids
or the Unique domain are lost. In the inactive form of c-Src,
the SH3 domain interacts with the proline-rich segment con-
necting the SH2 and SH1 domains. This interaction is at least
partially released when c-Src is activated. With the observed
allosteric effects of PPP binding, it is tempting to speculate
on the possible reverse signaling in which the activation state, 893–902, May 5, 2015 ª2015 Elsevier Ltd All rights reserved 899
Figure 7. Effect of the PPP on the SH3-Lipid
Interaction
(A) Combined 1H-15N chemical shift changes of
USrc-SH3 induced by the presence of 8% w/v
DHPC/DMPG bicelles.
(B) Combined 1H-15N chemical shift changes be-
tween USrc-SH3 WT construct in the presence of
PPP and in the presence of PPP + DHPC/DMPG
bicelles.
(C) Combined 1H-15N CSPs between USrc-SH3
WT construct in the presence of DHPC/DMPG
bicelles and in the presence of DHPC/DMPG
bicelles + PPP (only USrc residues are shown).
(D) Combined 1H-15N chemical shift changes be-
tween USrc-SH3 WT construct in the presence of
DHPC/DMPG bicelles and in the presence of
DHPC/DMPG bicelles + PPP (only SH3 residues
are shown). Notice the expanded Dd scale asso-
ciated with PPP binding. Arrows mark SH3 resi-
dues known to be directly interacting with PPP
(long for the core, short for additional regions).
Gray circles indicate proline residues. The dashed
line represents one SD. See also Figure S2.of c-Src is transmitted to the flexible Unique and SH4 domains
modulating their interaction with lipids.
EXPERIMENTAL PROCEDURES
Cloning and Mutagenesis
The cDNA encoding for the human c-Src SH4 and Unique domains (USrc,
residues 1–85) plus a C-terminal Strep-tag (SAWSHPQFEK) inserted for
purification purposes was cloned into a pET-14b vector (Novagene). The
human c-Src SH3 domain construct (SH3, residues 86–150) or bound to the
c-Src N-terminal region (USrc-SH3, 1–150) were cloned into a pETM-30 vector
(EMBL) after a TEV cleavage site and expressed as His6-GST fusion proteins.
Site-directed mutations were introduced using the QuikChange mutagenesis
kit (Stratagene).
Protein Expression and Purification
The plasmids carrying the proteins of interest were transformed in Escherichia
coli Rosetta (DE3)pLysS cells (Novagen). Cells were grown in M9 minimal me-900 Structure 23, 893–902, May 5, 2015 ª2015 Elsevier Ltd All rights reserveddium supplemented with 15N (15NH4Cl from Cam-
bridge Isotope Laboratories). Protein expression
was carried out at 25C overnight after induction
with 1 mM isopropyl b-D-1-thiogalactopyranoside
(IPTG). Cells were then harvested and sonicated.
USrc protein was purified from the cell lysate using
Strep-tactin Sepharose resin (IBA) and eluted with
2.5 mM desthiobiotin. His6-GST-SH3 and His6-
GST-USrc-SH3 constructs were recovered from
the cell lysate with Ni-NTA resin (Qiagen) and
elutedwith 400mM imidazole. Overnight digestion
with His-tagged TEV protease was performed at
4C in order to remove the GST tag protein. Imid-
azole was then removed from solution using PD-
10 desalting columns (GE Healthcare). Digested
products were incubated again with Ni-NTA resin
at room temperature for 1 hr. The flow-through
containing only the protein of interest was
collected.
Further purification was performed with size
exclusion chromatography in a Superdex 75 26/
60 column (GE Healthcare). For USrc constructs,
50 mM sodium phosphate buffer, 0.2 mM EDTA,and 0.01% NaN3 at pH 7.0 was used. For SH3 and USrc-SH3, the buffer
was 50 mM sodium phosphate, 150 mM NaCl, 0.2 mM EDTA and 0.01%
NaN3 at pH 7.5. The protein-containing fractions were pooled, concentrated
to the desired concentration (Centricon 5 kDa, Millipore), and stored at 4C.
Further details about USrc purification protocols are described in Pe´rez et al.
(2013b). Synthetic peptides SH4 and PPP were added as 40 mM stock solu-
tions in MilliQ H2O to minimize dilution effects upon addition to the NMR
samples.
NMR Spectroscopy
After purification, all 15N labeled samples were dissolved in 50 mM sodium
phosphate buffer (pH 7.0) with 90% H2O/10% D2O. Protein concentrations
were in the range of 0.2–0.3 mM in all measurements.
All experiments were performed in a Bruker 600 MHz Advance III spectrom-
eter equipped with a TCI CryoProbe (Unitat de RMN, Universitat de
Barcelona).
Either 1H-15N HSQC or 1H-15N SOFAST-HMQC (band-selective optimized-
flip-angle short-transient heteronuclear multiple-quantum correlation)
(Schanda et al., 2005) experiments were carried out at pH 7.0 at 278 K,
Figure 8. Cartoon Models Showing SH4-Unique-SH3 Interactions
The gray sphere represents the SH3 domain. The black line corresponds to the Unique domain, which is connected to the back of the SH3 domain. Residues or
regions experimentally detected to be involved in interactions are indicated. The yellow oval represents the lipid bicelle (not to scale).
(A) USrc-SH3 WT. Residues E60 and N68 are located at the beginning and at the end of the ULBR, respectively.
(B) USrc-SH3 AAA. Most of the inter-domain contacts outside the ULBR are retained. This mutation also affects the conformational space sampled by USrc.
(C) USrc-SH3-PPP complex. SH3-Unique contacts are abolished while the N-SH4-SH3 interaction is maintained.
(D) USrc-SH3 in the presence of lipids. SH4, ULBR (USrc), and the RT and nSrc loops of SH3 are involved in lipid binding. USrc-SH3 contacts are
conserved.
(E) USrc-SH3-PPP complex in the presence of lipids. Direct SH3-lipids interaction is abolished. ULBR and SH4 interact with lipids. The SH4-SH3 interaction is
retained.optimum for observing Unique domain signals, or 298 K, better suited to
observe the SH3 domain and samples with lipid bicelles.
NMR spectra were processed using Bruker TopSpin 3.0 and NMRPipe
(Delaglio et al., 1995), and analyzed using Sparky (Goddard and Kneller,
2004).
Combined chemical shift differences were calculated using the following
equation:
Dd=
h
ðDdHÞ2 + ðDdN=5Þ2
i1=2
(Equation 1)
Individual chemical shifts differences larger than one SD from themean of all
measured differences in the relevant pair of spectra were considered statisti-
cally significant.
USrc and USH3 assignments had been previously reported (Pe´rez et al.,
2009, 2013a). SH3 backbone assignment in the presence of a PPP was based
on literature values (BRMB 4889) measured at pH 6.5 and 298 K.
Molecular images were generated using VMD 1.9.2 (Humphrey et al., 1996)
or Chimera (Pettersen et al., 2004).Structure 23PRE Experiments
The paramagnetic tag used for spin labeling was MTSL ((1-oxy-2,2,5,5-tetra-
methyl-D-pyrroline-3-methyl)-methanethiosulfonate). The cysteine-containing
mutants were purified following the same previously described protocol with
5 mM DTT on each step to avoid disulfide-bond formation. For the protein-
tagging reaction, DTT was removed using a desalting PD-10 column and a
16-fold excess of MTSL was added to the protein solution. After overnight re-
action at 4C, the MTSL excess was eliminated using a desalting column.
Addition of a 5-fold excess of ascorbic acid to the protein solution was used
to reduce the nitroxide radical and provide the control diamagnetic sample.
Theoretical PRE profiles were calculated using Flexible Meccano 1.1
(Ozenne et al., 2012). 50,000 conformer ensembles were generated for each
construct. The intrinsic 1H linewidth parameter was obtained from the average
linewidth of the 1H signals in the diamagnetic sample.
Lipid Bicelle Preparation
Negatively charged bicelles were prepared using a mixture of short-chain
(DHPC) and long-chain (DMPG) lipids in a molar ratio of 1.0:0.8 DHPC/DMPG, 893–902, May 5, 2015 ª2015 Elsevier Ltd All rights reserved 901
(q = 0.8, 44.4% DMPG molar ratio), which provides isotopic fast tumbling bi-
celles (Glover et al., 2001; Vold et al., 1997). The lipids were dissolved in
chloroform mixtures and the solvent was evaporated in vacuo. The resulting
lipid film was rehydrated in 50 mM phosphate buffer (pH 7.0). The mixture
was then vortexed and subjected to freeze and thaw cycles with vortexing
and pipetting. Concentrated protein stocks and D2O were then added to
the clear bicelle solution to a final concentration of 8% (w/v) lipids, 0.2 mM
protein, and 10% D2O.
Further details about bicelle preparation protocols are described in Pe´rez
et al. (2013b).
Reagents and Chemicals
Synthetic peptides SH4 (residues 2–19, GSNKSKPKDASQRRRSLE) and PPP
(Ac-VSLARRPLPPLP-OH) were synthesized and purified by GenScript.
IPTGwas purchased fromMelford; MTSL paramagnetic tag was purchased
from Toronto Research Chemicals; DHPC and DMPG lipids were
purchased from Avanti Polar Lipids; the rest of the salts and reagents were
purchased from Sigma.
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